atrial fibrillation and chronic heart failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 30-80 years old, gender unlimited; 2. Meet the diagnostic criteria; 3. Good compliance; 4. Sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Exclude the abnormality of blood glucose, blood lipid and blood pressure caused by other primary diseases (chronic kidney disease, chronic liver disease and hypothyroidism); 2. Complicated with serious cardiovascular and cerebrovascular diseases, such as acute heart failure, severe hypertension, cerebral hemorrhage, etc; 3. Patients with severe liver dysfunction (ALT or ast reaching more than 3 times the upper limit of normal value), endocrine diseases, malignant tumors and autoimmune diseases; 4. Pregnant, pregnant or lactating women; 5. Allergic constitution and allergic to the components of this study; 6. Those who are participating in other clinical trials or have participated in other drug clinical trials for less than 1 month. 7. Patients with valvular atrial fibrillation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6-minute walking test; | — |
Secondary
| Measure | Time frame |
|---|---|
| Echocardiographic parameters;Classification of cardiac function;Biochemical indicators;NT-proBNP;dynamic electrocardiogram;Symptoms of traditional Chinese medicine;Psychological scale score; | — |
Countries
China